top of page
Search

Are deceased and people with injuries after COVID19 mRNA tested?

  • jearungby
  • 4 days ago
  • 12 min read

Updated: 3 days ago

 

By specialist Jeanne A. Rungby. Rungbyclinic.com


The NORTH Group has prepared a letter for doctors and other professionals working in pathology.


Pathology is the specialty that typically looks at tissue samples from biopsies under a microscope to find out what is wrong with the patient, but also at entire organs from deceased persons to determine the cause of death.


The NORTH Group would like to know about any expert opinions on histopathological findings after COVID-19 vaccination.


The letter requests a dialogue about the microscopic findings reported in scientific articles in humans after injection of modified mRNA COVID-19 vaccines. In particular, the doctors in the NORTH Group would like to hear what experiences these pathologists have had over the last 4-5 years after the administration of mRNA vaccines and whether these experiences speak against the findings reported in the aforementioned articles.


The letter refers to 3 major pathological examinations of the deceased:


1. An analysis of 28 deaths attributed to vaccine-induced myocarditis (heart muscle inflammation) found a mean time from vaccination to death of 6.2 days, with a mean age of 44.4 years (1). This study found that relatively young people died within a week of vaccination.


2. A larger analysis of 325 deaths showed that 73.9% were independently assessed as being directly caused by or significantly contributed to by vaccination. (2) The primary causes of death were cardiovascular-related (49% of cases), including sudden cardiac death (35%), myocardial infarction (12%), and myocarditis (7.1%). The major organs affected were the heart and blood vessels.


3. The 3rd study refers to a book, a histopathological atlas (3) based on the work of the late Prof. Arne Burkhardt, written by an experienced pathologist Ute Krüger, who also contributed to the letter. In this atlas, typical findings from microscopy are described: Accumulation of immune cells in the tissue around both small and large blood vessels (lymphocytic vasculitis) was observed in almost 90% of the cases examined. Accumulation of immune cells in was also found in heart muscle tissue (myocardial inflammation) in over 50% of the cases.


New science on heart muscle inflammation:


In a recent scientific study (22), which unfortunately did not make it into the references in the letter from the NORTH Group, it has just been revealed why young people with a strong immune system, in particular, are at risk of developing myocarditis after COVID19 mRNA vaccination. In the new study (22), the researchers have discovered that a small piece of the vaccine spike protein triggers an immune response that also targets certain proteins in heart muscle cells. The two protein pieces are so similar that the immune system cells cannot distinguish the two from each other. This is called molecular mimicry. Unvaccinated patients who had COVID19 did not develop this autoimmune reaction, where the T cells attack heart muscle cells. The researchers could not explain why the same damage was not seen after COVID19 infection. Spike proteins are involved in both COVID19 and after COVID19 vaccination. However, the two spike proteins are not exactly the same.


The researchers tested their studies on mice and concluded that this study confirmed their findings. This means that if the modified mRNA from the vaccine goes to the heart muscle cells, then the recipient of the vaccine is more likely to develop heart muscle inflammation by the described mechanism.

The researchers also believed that if the vaccine is given into the respiratory tract (nose or lungs), there was a greater risk that mRNA would go directly to the heart and thereby trigger myocarditis, as it would not be captured in lymphatic tissue, which is more likely to happen when the vaccine is given into the arm or leg (mice).


mRNA in the oral cavity by microinjection:


The Serum Institute and DTU are jointly putting the finishing touches on the development of a COVID19 lipid nanoparticle-based vaccine that can be administered into the oral mucosa using microneedles(23,24). 6.2 million DKK has been allocated from the Independent Research Foundation of Denmark, paid for by Danish taxpayers, for this development. The argument for administering the vaccine by microinjection into the oral mucosa is that this avoids spread via the bloodstream to the rest of the body and that this reduces the possibility of infection.


I wonder if these researchers from DTU and SSI have considered the risk that their new Covid19 vaccine for the oral cavity may increase the risk of myocarditis in recipients? I have asked Grok if there is cause for concern when such a vaccine is given in the oral cavity via microinjection: Answer “ The full text ( 22 ) explicitly warns against increased myocarditis risk by respiratory mucosal routes due to higher biodistribution. The oral cavity is part of the respiratory system with similar vascularization (many small blood vessels) as the nose, so microneedle delivery here could have the same "paradoxical" effect: Better local immunity, but greater chance that Spike protein ( probably rather modified mRNA ) reaches the heart via lymph/blood.”


It is indeed very unfortunate that this imitation can cause myocarditis, and should of course have been investigated before the rollout of these products. Complete biodistribution studies and dose/effect studies were not conducted before approval.


This should be seen in particular in light of the fact that the Danish Health Authority very early in the process, in fact before healthy children and young adults were encouraged in a letter from the Danish Health Authority to receive this vaccine to protect others, knew this risk of myo-pericarditis. The Danish Health Authority also knew that the vaccine did not protect against transmission, before they sent out the letter and put strong pressure on young people, including in bus advertisements, to take this untested product (no phase 3 clinical trials based on the commercial product in process 2). Shortly before that, they had warned all Danish doctors in E-Boks about the risk of myocarditis with this mRNA vaccine. They were thus aware of the risk.

 

The letter from NORTH Group: Seen in a broader context:


Excess mortality


The letter from NORTH Group also refers to a selection of studies (4 – 8) showing that mortality - not attributable to COVID19 - increased dramatically in populations shortly after the administration of these mRNA products worldwide. One of these studies showed a 14.5% higher mortality rate among the vaccinated compared to the unvaccinated (5).

Excess mortality due to heart disease has also been found (9,10,11).

The British Heart Foundation reported an excess of 100,000 cardiac deaths in England between March 2020 and June 2023 (14). The 50-64 age group had a 33% higher incidence of cardiovascular deaths (15). An analysis has found a correlation between the excess number of cardiac deaths and vaccination rates at a regional level (16).

 

Cancer


Changes in the incidence of cancer:

There are 2 recent large population studies that are particularly noteworthy;

1. A South Korean analysis of 8.4 million people found increased risks of blood cancer and other cancers after COVID19 vaccines (12)

2. A 30-month population study in an Italian province reported a significant increase in cancer hospitalization rates among the vaccinated population (13).

 

NORTH Group's key questions for pathologists address the following:


· Have they noticed an increase in autopsies with the signs described in the studies, especially in younger populations?

· Have they used immunohistochemical staining (e.g. for spike and nucleocapsid proteins) in such cases?

· Have they encountered cases of unusually aggressive or rapidly developing cancers that they found noteworthy.

· Do they have access to protocols to better investigate these potential connections in relevant cases?


We will keep you posted in case of answers.

 

Below you can read the long version of the letter from NORTH Group translated into Danish.

 

 

Collaborative Inquiry: Seeking Your Expert Opinion on Histopathological Findings Post-COVID-19 Vaccination


November 2025

Dear Colleague,

We are reaching out to you as an expert in Pathology to solicit your professional perspective on observations that have been raised by international colleagues.

You play a critical role in diagnosing patients accurately and in monitoring health changes from a broader perspective. This is especially important in the post-marketing surveillance of new medical products, where the identification of potential adverse events relies heavily on pathological expertise.


Discussions around the efficacy and safety of COVID-19 vaccines have been varied. In the interest of objectivity and patient safety, we believe it is essential to focus on the available data to form a rational, evidence-based opinion. This is especially important given the intention to use genetic vaccine technology instead of traditional vaccines.


Whilst the significance of some reported health impacts may be debated, the volume of peer-reviewed publications describing diverse aspects of COVID-19 vaccine-associated findings suggests this is a area requiring professional diligence. This is particularly relevant given the accelerated timeline for the approval of these products.


As professionals with a high degree of ethical responsibility, the Precautionary Principle is a relevant consideration. Potential risks of new medical products must be taken seriously. There is a duty of care to ensure that patient safety is prioritized.


Medical science can be influenced by competing interests, be they economic, political, or social in nature. It is therefore important that professionals who have observations based on data are heard, to ensure that informed consent is based on an environment of openness and transparency.


COVID-19 vaccines were rolled out under unique circumstances. Some have raised questions about whether passive pharmacovigilance systems were sufficient to characterise potential harms, given the speed and scale of the rollout. A number of experts have expressed concerns regarding the potential risks to health.


We represent a body of experts from various disciplines who are seeking to better understand the available safety signals. We would like to hear from you about your professional observations over the past 5 years, particularly in light of the scientific evidence presented below, which is a selection of what has been described in the literature, based on autopsies and pathological examinations.


Systematic reviews of autopsies conducted after COVID-19 vaccination


Two recent scientific review articles deal specifically with pathological and histological findings after COVID-19 vaccination.

The first study by Hulscher et al. (Jan 2024)[1] describes autopsy findings and histological examination of 28 deceased where the cause of death, based on the Bradford Hill criteria, was attributed to COVID-19 vaccination. The article's conclusion reads:

“The cardiovascular system was the only organ system affected in 26 cases. In two cases, myocarditis was characterised as a consequence of a multisystemic inflammatory syndrome. The average age at death was 44.4 years. The mean and median number of days from last COVID-19 vaccination to death was 6.2 and 3 days, respectively. We determined that a causal relationship between all 28 deaths and COVID-19 vaccination was most likely by independently reviewing the clinical information in each article. Thus, the study suggests that there is a high likelihood of a causal association between COVID-19 vaccines and death from myocarditis.”

Another review by Hulscher et al. (Nov 2024)[2] includes a systematic review of autopsy findings in decedents following COVID-19 vaccination. This study includes:

“325 autopsy cases. The average age at death was 70.4 years. The most involved organ system among the cases was the cardiovascular (49%), followed by haematological (17%), respiratory (11%) and multiple organ systems (7%). Three or more organ systems were affected in 21 cases. The average time from vaccination to death was 14.3 days. Most deaths occurred within one week of the last vaccination. A total of 240 deaths (73.9%) were independently assessed as directly caused or substantially contributed to by COVID-19 vaccination, of which the primary causes of death included sudden cardiac death (35%), pulmonary embolism (12.5%), myocardial infarction (12%), VITT (7.9%), myocarditis (7.1%), multisystem inflammatory syndrome (4.6%), and stroke (3.8%).”

The authors conclude that a causal link is highly likely and that further studies are needed.


Case series from Professor Arne Burkhardt


A new histopathological atlas co-authored by pathologist Ute Krüger (2025),[3] describes histological studies of tissue from people who died after mRNA injections.

These studies are based on the autopsy findings of Professor Arne Burkhardt. Tissue samples were examined by histological methods including immunohistochemistry for Spike protein.

The work emphasises the importance of a multi-organ approach to autopsies. The most consistent finding was vascular inflammation. In almost 90% of cases, lymphocytes were found in the tissue surrounding vessels. Endothelial cells were seen to disintegrate and become detached.

In more than 50% of cases, inflammation was observed in the heart. Spike protein expression was identified, in association with pathological abnormalities, in heart tissue, vessels and brain tissue.

At the time of the analysis, immunohistochemistry for the viral nucleocapsid protein was used as a control to suggest the spike protein was vaccine-derived. It is now possible to more specifically distinguish between viral- and vaccine-derived Spike protein.

We would be interested to hear if you have implemented such analytical methods in your workplace.


Excess mortality.


Since 2021, non-COVID excess mortality has been recorded in many countries with high COVID-19 vaccine uptake, especially in younger age groups.[4],[5],[6],[7],[8] Pathologists are crucial in investigating the pathogenic signatures underlying mortality trends. This excess was accompanied by an increase in disability claims[9] and was observed in countries including Australia and Singapore.[10],[11] As these countries had high vaccination uptake but a lower burden of COVID-19 infection, investigating the cause of this mortality is a pertinent scientific question.

A study by Sorli 5 reported that 6.08 million more people died in 2021 than in 2020. This contrasts with modelling studies that claimed COVID-19 vaccination saved 14 million lives,[12] a conclusion dependent on questionable assumptions.[13] Sorli's analysis of real-world data suggested that mortality in the vaccinated population in 2021 was 14.5% higher than in the unvaccinated population.


Cardiac deaths


Excess cardiac deaths have disproportionately affected younger age groups. The British Heart Foundation reported an excess of 100,000 cardiac deaths in England between March 2020 and June 2023.[14] The 50–64-year age group had a 33% higher rate of cardiovascular death.[15] One analysis has correlated excess cardiac deaths with vaccination rates at a regional level.[16]


Increase in cancer cases


Pathologist Ute Krüger has reported observing an increase in younger women diagnosed with fast-growing breast cancers, which she termed 'turbo cancers'.3 These clinical observations are now being supported by large-scale epidemiological studies. A recent South Korean national cohort study found significantly increased risks for specific malignancies, including hematological cancers, following COVID-19 vaccination.[17] Similarly, a 30-month cohort study in an Italian province reported a significant increase in cancer hospitalization rates among the vaccinated population.[18]

The presence of residual DNA in the final product has been reported by independent researchers to be above regulatory limits. The presence of the SV40 promoter/enhancer has been noted as a potential theoretical risk due to its known biological activity,[19] as outlined in a recent letter of concern from NORTH Group to prime ministers and health ministers from 27 countries.[20]

Although health authorities have not established a link, some data suggests changes in cancer incidence since 2022. The figure below shows a rise in the number of young people in the UK seeking financial support due to a cancer diagnosis[21]:


ree

Figure 1. Personal Independence Plan (PIP) claims, January 2016-February 2023, UK


Our request to you.


This is only a small selection of studies that document observations following COVID-19 vaccination. We are interested in your professional experiences.

Have you noticed:a) An increase in sudden and/or unexpected deaths among younger people?b) More cardiovascular-related deaths?c) Cardiac deaths in low risk groups?d) Changes in cancer diagnoses including a younger demographic, rarer types, higher stage presentations and an increased incidence of dual primaries?e) A change in the diagnostic picture in autopsies and histological results?If yes, please describe these changes.f) Do you have access currently to immunohistochemistry for spike protein – if not, would you be willing to set this up in your laboratory?

Please mail any comments to contactus@northgroup.info

We thank you for your time and interest. We hope to open a dialogue about these observations, in recognition of our shared duty of care to investigate and report potential adverse events.


With respect,

Dr. Clare Craig, BMBCh FRCPath, Diagnostic Pathologist, Chair HART Group

Dr. Ute Krüger, MD, Diagnostic Pathologist

 


Dr. Jeanne Rungby, MD, Otorhinolaryngologist                 


Dr. Jonathan Gilthorpe, PhD

Associate Professor of Experimental Neuroscience

 

Dr. Sven Román, MD,

Child and Adolescent Psychiatrist


Dr. Ros Jones, MD, FRCPCH

Retired Consultant Paediatrician

 

Hanna Parikka, MSc

Former IVF Biologist & Biotechnologist

 

Agita Galina, Mg.iur, BA, LlM

Lawyer & Social Worker

 

Dr. David J. Speicher, PhD

Molecular Virologist & Pathobiologist



REFERENCES

 

 

IMPORTANT REFERENCES:

Autopsy and histopathology:

1 Hulscher N, et al. (Jan. 2024). Autopsy findings in a case of fatal COVID-19 vaccine-induced myocarditis. ESC Heart Failure. https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.14680

2 Hulscher N, et al. (November 2024). A systematic review of autopsy findings in deaths after COVID-19 vaccination. Public Health Policy Journal. https://publichealthpolicyjournal.com/asystematic-review-of-autopsy-findings-in-deaths-after-covid-19-vaccination/

3 Krüger U, Lang W. (2025) Vaccinated – dead. A histopathological atlas. www.histo-atlas.com

Excess mortality:

4 Rancourt D, et al. (2024). Spatiotemporal variation of excess all-cause mortality in the world (125 countries) during the Covid period 2020-2023. Correlation-Canada.org . https://correlationcanada. org/covid-excess-mortality-125-countries/

5 Sorli S. (2024). The discrepancy between the number of lives saved with COVID-19 vaccination and statistics from Our World Data. https://www.longdom.org/open-access/thediscrepancy-between-the-number-of-saved-lives-with-covid19-vaccination-and-statistics-ofour-world-data.pdf

6 Mostert S, et al. (2024). Excess mortality in Western countries since the COVID-19 pandemic. BMJ Public Health. https://bmjpublichealth.bmj. com/content/2/1/e000282

7 Alessandria M, et al. (2024). A critical analysis of all-cause mortality during COVID-19 vaccination in an Italian province. Microorganisms. https://www.mdpi.com/20762607/12/7/1343

8 Wrigley-Field E, et al. (2024). Mortality trends among young adults in the United States,

Cardiac death:

10 Pulse Today. (2023). Heart disease continues to drive excess deaths after pandemic, study finds. https://www.pulsetoday.co.uk/news/clinical-areas/cardiovascular/heart-disease-continuesto-drive-excess-post-pandemic-deaths-study-finds/

Concerns about cancer:

12 Kim, H., Kim, MH., Choi, M. et al. 1-year cancer risks associated with COVID-19 vaccination: a large population-based cohort study in South Korea. Biomark Res 13, 114 (2025). https://doi.org/10. 1186/s40364-02 5-008 31-w

13 Martellucci A, et al. (2025). COVID-19 vaccination, all-cause mortality and hospitalisation for cancer: 30-month cohort study in an Italian province. https://doi.org/10.17179/excli20258400

Additional references regarding excess mortality:

14. HART Group. (2023). We rightly mourn the dead, but we must not forget the disabled.

HART Group. (2023). A closer look at deaths in Australia in 2021 https://hartuk.substack. com/p/australian-deaths

15. HART Group. (2023) Singapore: A case study. https://hartuk.substack. com/p/singapore-2

16. HART Group. (2022) The impact of synthetic spike protein.

17. Watson OJ, et al. (2022). Global impact of the first year of COVID-19 vaccination: a mathematical modeling study. Lancet Infect Dis. https://doi.org/10.1016/S14733099(23) 00566-2

18. Ophir Y, et al. (2025). A Step-by-Step Evaluation of the Claim That COVID-19 Vaccines Saved Millions of Lives. https://www.fortunejournals.com/articles/a-stepbystep-evaluationof-the-claim-that-covid19-vaccines-saved-millions-of-lives.html

Additional references regarding cancer risk:

19. Senigl F, et al. (2024). The SV40 virus enhancer functions as a somatic hypermutation target element with potential tumorigenic activity. https://www.sciencedirect.com/science/article/pii/S266667902400017X

20. NORTH Group. (November 2024). Letter of Concern to Health Ministers and Prime Ministers. https://northgroup.info/pdfs/NORTH_Group_Letter-2024-11-25.pdf

21. Dalby ER, Alegria C, UK PIP Analysis – Causes. https://phinancetechnologies.com/HumanityProjects/PIP%20Analysis-Causes.htm


Later science and sources not included in the letter:

22. Study on molecular mimicry and explanation of myo-pericarditis after COVID19 vaccination: https://pubmed.ncbi.nlm.nih.gov/41164857/

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 

Comments

bottom of page